dc.creatorCastillo, Natalia Alejandra
dc.creatorValdez, Alejandra Leonor
dc.creatorFariña, Julia Inés
dc.date.accessioned2017-05-23T15:29:24Z
dc.date.accessioned2018-11-06T14:16:36Z
dc.date.available2017-05-23T15:29:24Z
dc.date.available2018-11-06T14:16:36Z
dc.date.created2017-05-23T15:29:24Z
dc.date.issued2015-10-15
dc.identifierCastillo, Natalia Alejandra; Valdez, Alejandra Leonor; Fariña, Julia Inés; Microbial production of scleroglucan and downstream processing; Frontiers; Frontiers in microbiology; 6; 1106; 15-10-2015; 1-19
dc.identifier1664-302X
dc.identifierhttp://hdl.handle.net/11336/16860
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1884688
dc.description.abstractSynthetic petroleum-based polymers and natural plant polymers have the disadvantage of restricted sources, in addition to the non-Biodegradability of the former ones. In contrast, eco-sustainable microbial polysaccharides, of low-cost and standardized production, represent an alternative to address this situation. With a strong globalmarket, they attracted worldwide attention because of their novel and unique physico-chemical properties as well as varied industrial applications, and many of them are promptly becoming economically competitive. Scleroglucan, a β-1,3-β-1,6- glucan secreted by Sclerotium fungi, exhibits high potential for commercialization and may show different branching frequency, side-chain length, and/or molecular weightdepending on the producing strain or culture conditions. Water-solubility, viscosifying ability and wide stability over temperature, pH and salinity make scleroglucan useful for different biotechnological (enhanced oil recovery, food additives, drug delivery,cosmetic and pharmaceutical products, biocompatible materials, etc.), and biomedical(immunoceutical, antitumor, etc.) applications. It can be copiously produced at bioreactor scale under standardized conditions, where a high exopolysaccharide concentration normally governs the process optimization. Operative and nutritional conditions, as well as the incidence of scleroglucan downstream processing will be discussed in this chapter. The relevance of using standardized inocula from selectedstrains and experiences concerning the intricate scleroglucan scaling-up will be also herein outlined.
dc.languageeng
dc.publisherFrontiers
dc.relationinfo:eu-repo/semantics/altIdentifier/url/http://journal.frontiersin.org/article/10.3389/fmicb.2015.01106/abstract
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fmicb.2015.01106
dc.rightshttps://creativecommons.org/licenses/by/2.5/ar/
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPOLYSACCHARIDES
dc.subjectMICROBIAL EPS
dc.subjectFERMENTATION
dc.subjectAPPLICATIONS
dc.subjectBIOREACTOR
dc.subjectNON-CONVENTIONAL SUBSTRATES
dc.titleMicrobial production of scleroglucan and downstream processing
dc.typeArtículos de revistas
dc.typeArtículos de revistas
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución